IP Verse

Sanofi Aventis Deutschland competitive analysis

Loading summary...

Latest oppositions filed by Sanofi Aventis Deutschland

Explore patent oppositions filed by Sanofi Aventis Deutschland against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3668568
Dosage Measurement Module On Injection PenELI LILLYMar 7, 2025
EP4017557
Methods And Apparatus For Aspects Of A Dose Detection SystemELI LILLYNov 4, 2024
EP3706841
Needle Shield Remover And A Medicament Delivery Device Comprising The Needle Shield RemoverSHL MEDICALAug 22, 2024
EP3184138
Needle Cover AssemblySHL GROUPJan 12, 2024
EP3666797
Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (Pcsk9)AMGENNov 10, 2023
EP3740265
A Medicament Delivery Device With A Removable Cap And Locking Member For Preventing Accidental ActiviationCONSORT MEDICALAug 16, 2023
EP3359229
Injector Comprising A Destructible Electric Circuit As A Result Of UseTECPHARMA LICENSINGFeb 16, 2023
EP3071262
Rotary Sensor Assembly With Space Efficient DesignNOVO NORDISKDec 22, 2020
EP3265152
Data Acquisiton Means, Especially For A Pen-Type Drug Delivery DevicesBEREYOct 22, 2020
EP2296728
Administration Device Having A Button With Touch SensorF HOFFMANN LA ROCHEJul 30, 2020

Latest patents of Sanofi Aventis Deutschland opposed by its competitors

Explore Sanofi Aventis Deutschland's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3774838
Sep 3, 2025Lixisenatide Synthesis With Capping2
EP3258992
May 28, 2025Data Collection Device For Attachment To An Injection Device2
EP3380136
Apr 30, 2025Auto-Injector2
EP3503946
Dec 11, 2024A Device For Attachment To An Injection Device1
EP4056212
Oct 9, 2024Autoinjector1
EP2788050
Nov 29, 2023Syringe Carrier1
EP3307357
Jun 7, 2023Data Collection Apparatus For Attachment To An Injection Device1
EP3153196
Jan 11, 2023Syringe Carrier2
EP3254616
Jun 9, 2021Medical Device And Method For Providing Information For Glycemic Control1
EP2536456
Apr 28, 2021Automatic Injection Device With Torsional Spring1

Latest publications and patents of Sanofi Aventis Deutschland New

Explore the latest publications and patents granted to Sanofi Aventis Deutschland, showcasing their recent innovations and technological advancements.

Last updated on: Oct 21, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Sanofi Aventis Deutschland

EP3774838
Sep 3, 2025Lixisenatide Synthesis With CappingPatent Maintained As Amended
EP4571274
Aug 20, 2025Sensor, Cartridge And Drug Delivery DevicePending
EP4069338
Aug 20, 2025Dosing Mechanism With Rotational End Stop Mechanism For Terminating Dose DispenseGranted
EP3731902
Aug 20, 2025Data Collection Apparatus For Attachment To An Injection DeviceGranted
EP3380134
Aug 20, 2025Medicament Injection DeviceGranted
EP4593960
Aug 6, 2025Anti-Cd28 AntibodiesPending
EP4556038
Aug 6, 2025AutoinjectorPending
EP4593035
Jul 30, 2025Predicting Disease SeverityPending
EP4593021
Jul 30, 2025Augmenting Real World Patient Data To Include Proxy Endpoint DataPending
EP4591905
Jul 30, 2025Electronic Add-On Module And Assembly Of An Electronic Add-On Module And A Drug Delivery DevicePending

Latest PTAB cases involving Sanofi Aventis Deutschland

Discover the latest PTAB cases involving Sanofi Aventis Deutschland, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 27, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Sanofi Aventis Deutschland

IPR2019-01658Oct 7, 2019MYLAN PHARMACEUTICALSSANOFI AVENTIS DEUTSCHLANDInstitution Denied
IPR2019-00977May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDTerminated-Other
IPR2019-00978May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDTerminated-Other
IPR2019-00979May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDFinal Written Decision
IPR2019-00980May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDTerminated-Other
IPR2019-00981May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDTerminated-Other
IPR2019-00982May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDTerminated-Other
IPR2019-00987May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDTerminated-Other
IPR2019-01022May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDTerminated-Other
IPR2019-01023May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDTerminated-Other

Peer Comparison New

IP litigation analysis comparing Sanofi Aventis Deutschland with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SANOFI AVENTIS DEUTSCHLAND1630 - 24
MYLAN PHARMACEUTICALS - - 94 -
PFIZER51874312
YPSOMED1814 - -